0001950047-24-005692.txt : 20240730 0001950047-24-005692.hdr.sgml : 20240730 20240730175817 ACCESSION NUMBER: 0001950047-24-005692 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240730 DATE AS OF CHANGE: 20240730 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 241159181 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: ZANTE GREG CENTRAL INDEX KEY: 0001264949 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O SANGAMO BIOSCIENCES, INC STE-A-100 STREET 2: POINT RICHMOND TECH, 501 CANAL BLVD, CITY: RICHMOND STATE: CA ZIP: 94804 144 1 primary_doc.xml 144 0001264949 XXXXXXXX LIVE 0001607678 VIKING THERAPEUTICS, INC. 001-37355 9920 Pacific Heights Blvd, Suite 350 San Diego CA 92121 (858) 704-4660 GREG ZANTE Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

16136 922232.10 110796200 07/30/2024 NASDAQ Common 07/29/2024 Performance Stock Units Issuer N 16136 07/29/2024 Services Rendered Y 07/30/2024 /s/ Greg Zante